To Compare the Efficacy and Safety of TW vs Valsartan in the DN.
Phase of Trial: Phase II
Latest Information Update: 23 Apr 2013
At a glance
- Drugs Tripterygium wilfordii Hook F (Primary) ; Valsartan
- Indications Diabetic nephropathies
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 26 May 2010 Actual patient number (67) added as reported by ClinicalTrials.gov.
- 26 May 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.